The healthcare analytics company will use the funds, raised in a Series C financing round, to scale its cloud-based platform that offers providers, payers and pharma companies insights to inform business decision-making.
The Good Pharma Scorecard focused on clinical trial data shared on 19 drugs approved in 2014.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.